Finance

Lists
THYROCARE:NSE
Thyrocare Technologies Ltd
487,40 ₹
-1,30%
(-6,40) 1D
15 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for THYROCARE...
Open
492,00 ₹
High
495,75 ₹
Low
484,35 ₹
Mkt. cap
77,64 млрд
Avg. vol.
269,12 м.
Volume
261,55 м.
Dividend
1,91%
Quarterly dividend
2,33 ₹
Ex-dividend date
2026 ж. 23 мау.
P/E ratio
44,29
52-wk high
662,00 ₹
52-wk low
342,55 ₹
EPS
11,00 ₹
Shares outstanding
52,76 млн
No. of employees
2 мың
Open
492,00 ₹
High
495,75 ₹
Low
484,35 ₹
Mkt. cap
77,64 млрд
Avg. vol.
269,12 м.
Volume
261,55 м.
Dividend
1,91%
Quarterly dividend
2,33 ₹
Ex-dividend date
2026 ж. 23 мау.
P/E ratio
44,29
52-wk high
662,00 ₹
52-wk low
342,55 ₹
EPS
11,00 ₹
Shares outstanding
52,76 млн
No. of employees
2 мың
News stories
From web sources and news partners
Profile
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
About Thyrocare Technologies Ltd
CEO-
Employees1,91 мың
Founded1996
HeadquartersНави Мумбаи, Махараштра, Үндістан
SectorHealth care provider
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
2,17 млрд
1,96 млрд
2,24 млрд
2,40 млрд
Cost of goods sold
932,90 млн
829,60 млн
1,17 млрд
1,02 млрд
Cost of revenue
932,90 млн
829,60 млн
1,17 млрд
1,02 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
292,50 млн
-
Operating expense
634,00 млн
763,70 млн
460,70 млн
734,70 млн
Total operating expenses
1,57 млрд
1,59 млрд
1,63 млрд
1,75 млрд
Operating income
598,40 млн
362,00 млн
613,70 млн
647,80 млн
Other non operating income
30,50 млн
50,70 млн
-112,20 млн
41,50 млн
EBT including unusual items
625,80 млн
353,90 млн
644,30 млн
682,90 млн
EBT excluding unusual items
625,80 млн
415,50 млн
525,80 млн
682,90 млн
Income tax expense
147,70 млн
73,40 млн
157,30 млн
169,60 млн
Effective tax rate
23,60%
20,74%
24,41%
24,84%
Other operating expenses
518,90 млн
547,40 млн
-126,20 млн
609,80 млн
Net income
479,90 млн
290,10 млн
471,10 млн
521,90 млн
Net profit margin
22,16%
14,84%
21,04%
21,74%
Earnings per share
-
2,11
2,98
3,22
Interest and investment income
-
-
34,00 млн
-
Interest expense
-5,90 млн
-
-15,20 млн
-13,50 млн
Net interest expenses
-5,90 млн
-
18,80 млн
-13,50 млн
Depreciation and amortization charges
115,10 млн
216,30 млн
140,30 млн
124,90 млн
EBITDA
713,00 млн
477,75 млн
711,78 млн
745,88 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары